Literature DB >> 22447439

Spy1 is frequently overexpressed in malignant gliomas and critically regulates the proliferation of glioma cells.

Li Zhang1, Aiguo Shen, Qing Ke, Wei Zhao, Meijuan Yan, Chun Cheng.   

Abstract

Spy1, a member of the Speedy/RINGO family, is a novel activator of cyclin-dependent kinases known to mediate cell cycle progression and cell survival in response to DNA damage. This study focused on the role of Spy1 in glioma oncogenesis. Immunohistochemistry and western blot analysis were performed to examine the expression of Spy1 in human glioma tissues and cell lines. Spy1 was frequently overexpressed in tumor tissues and cultured cells. Our data suggested that Spy1 expression positively correlated with the malignancy of gliomas. Altered expression of Spy1 led to changes in cell cycle processes, cyclin-dependent kinase 2 activity, and p27kip1 protein stabilization, ultimately disrupting cell growth rate. More importantly, high expression of Spy1 was associated with poor prognosis in patients with glioma, suggesting that Spy1 may be a novel independent prognostic predictor of survival for glioma patients. Collectively, this is the first report that Spy1 may play an essential role in the growth processes of human glioma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447439     DOI: 10.1007/s12031-012-9709-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  40 in total

1.  Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27.

Authors:  Christopher W McAndrew; Randy F Gastwirt; April N Meyer; Lisa A Porter; Daniel J Donoghue
Journal:  Cell Cycle       Date:  2007-05-30       Impact factor: 4.534

2.  Spy1 expression prevents normal cellular responses to DNA damage: inhibition of apoptosis and checkpoint activation.

Authors:  Randy F Gastwirt; Daniela A Slavin; Christopher W McAndrew; Daniel J Donoghue
Journal:  J Biol Chem       Date:  2006-09-02       Impact factor: 5.157

3.  The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis.

Authors:  Azadeh Golipour; Dorothy Myers; Tiffany Seagroves; Daniel Murphy; Gerard I Evan; Daniel J Donoghue; Roger A Moorehead; Lisa A Porter
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

Review 4.  Regulation of CDKs by phosphorylation.

Authors:  M J Solomon; P Kaldis
Journal:  Results Probl Cell Differ       Date:  1998

Review 5.  Cyclin-dependent kinases: engines, clocks, and microprocessors.

Authors:  D O Morgan
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

Review 6.  Cyclins and cyclin-dependent kinases: a biochemical view.

Authors:  J Pines
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

7.  Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins.

Authors:  A Karaiskou; L H Perez; I Ferby; R Ozon; C Jessus; A R Nebreda
Journal:  J Biol Chem       Date:  2001-07-18       Impact factor: 5.157

8.  Histone H1 phosphorylation by Cdk2 selectively modulates mouse mammary tumor virus transcription through chromatin remodeling.

Authors:  R N Bhattacharjee; G C Banks; K W Trotter; H L Lee; T K Archer
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 9.  Molecular pathogenesis of malignant gliomas.

Authors:  B K Rasheed; R N Wiltshire; S H Bigner; D D Bigner
Journal:  Curr Opin Oncol       Date:  1999-05       Impact factor: 3.645

Review 10.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

View more
  7 in total

1.  Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.

Authors:  Denise A McGrath; Bre-Anne Fifield; Aimee H Marceau; Sarvind Tripathi; Lisa A Porter; Seth M Rubin
Journal:  EMBO J       Date:  2017-06-30       Impact factor: 11.598

2.  Spy1 Protein Mediates Phosphorylation and Degradation of SCG10 Protein in Axonal Degeneration.

Authors:  Yonghua Liu; Youhua Wang; Ying Chen; Xiaohong Li; Jiao Yang; Yang Liu; Aiguo Shen
Journal:  J Biol Chem       Date:  2015-04-13       Impact factor: 5.157

3.  Spy1 induces de-ubiquitinating of RIP1 arrest and confers glioblastoma's resistance to tumor necrosis factor (TNF-α)-induced apoptosis through suppressing the association of CLIPR-59 and CYLD.

Authors:  Zongmei Ding; Yonghua Liu; Li Yao; Donglin Wang; Jianguo Zhang; Gang Cui; Xiaojing Yang; Xianting Huang; Fang Liu; Aiguo Shen
Journal:  Cell Cycle       Date:  2015-05-27       Impact factor: 4.534

4.  Direct interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro.

Authors:  Mohammad Al Sorkhy; Bre-Anne Fifield; Dorothy Myers; Lisa A Porter
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

5.  Temporal-spatial expressions of Spy1 in rat sciatic nerve after crush.

Authors:  Jianhua Cao; Jiao Yang; Youhua Wang; Jian Xu; Zhengming Zhou; Chun Cheng; Xiaojuan Liu; Xinghai Cheng; Long Long; Xingxing Gu
Journal:  Cell Mol Neurobiol       Date:  2012-11-06       Impact factor: 5.046

6.  Spy1 participates in the proliferation and apoptosis of epithelial ovarian cancer.

Authors:  Shumin Lu; Rong Liu; Min Su; Yingze Wei; Shuyun Yang; Song He; Xia Wang; Fulin Qiang; Chen Chen; Shuyang Zhao; Weiwei Zhang; Pan Xu; Guoxin Mao
Journal:  J Mol Histol       Date:  2015-12-07       Impact factor: 2.611

7.  Screening critical genes associated with malignant glioma using bioinformatics analysis.

Authors:  Yonggang Xu; Jie Wang; Yanbin Xu; Hong Xiao; Jianhua Li; Zhi Wang
Journal:  Mol Med Rep       Date:  2017-09-12       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.